MARKET

AMLX

AMLX

Amylyx Pharmaceuticals
NASDAQ
14.89
+0.67
+4.71%
After Hours: 15.30 +0.41 +2.75% 19:01 02/10 EST
OPEN
14.86
PREV CLOSE
14.22
HIGH
15.11
LOW
14.56
VOLUME
753.39K
TURNOVER
--
52 WEEK HIGH
17.49
52 WEEK LOW
2.600
MARKET CAP
1.64B
P/E (TTM)
-8.2741
1D
5D
1M
3M
1Y
5Y
1D
Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 19h ago
Amylyx Pharmaceuticals Price Target Raised to $28.00/Share From $20.00 by HC Wainwright & Co.
Dow Jones · 19h ago
HC Wainwright & Co. Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $28
Benzinga · 19h ago
Amylyx price target raised to $28 from $20 at H.C. Wainwright
TipRanks · 20h ago
AMYLYX PHARMACEUTICALS, INC. <AMLX.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $28 FROM $20
Reuters · 20h ago
Weekly Report: what happened at AMLX last week (0202-0206)?
Weekly Report · 1d ago
Top Amylyx Executives Quietly Unload a Wave of Company Shares
TipRanks · 6d ago
Amylyx Co-CEO Joshua B. Cohen Sells Common Shares
Reuters · 6d ago
More
About AMLX
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on three investigational therapies across several neurodegenerative and endocrine diseases. Its lead investigational asset is avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist. Avexitide has been evaluated as a treatment for Post-Bariatric Hypoglycemia (PBH) and congenital HI, two indications characterized by hyperinsulinemic hypoglycemia. In addition to avexitide, it is advancing AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol in Wolfram syndrome and progressive supranuclear palsy (PSP), and AMX0114 in amyotrophic lateral sclerosis (ALS). AMX0035 is designed to mitigate neurodegeneration by targeting endoplasmic reticulum stress and mitochondrial dysfunction, two cellular processes central to neuronal cell death and neurodegeneration. AMX0114 is an investigational antisense oligonucleotide.

Webull offers Amylyx Pharmaceuticals Inc stock information, including NASDAQ: AMLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMLX stock methods without spending real money on the virtual paper trading platform.